CompletedPhase 2NCT02406781
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial
Studying Bone sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut Bergonié
- Principal Investigator
- Antoine ITALIANO, MD, PhDInstitut Bergonié
- Intervention
- Combination of MK3475 with Metronomic CP(drug)
- Enrollment
- 129 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2023
Study locations (8)
- Institut Bergonié, Bordeaux, France
- Centre Oscar Lambret, Lille, France
- Centre Léon Bérard, Lyon, France
- Institut Paoli Calmettes, Marseille, France
- Institut Curie, Paris, France
- Institut de Cancérologie de l'Ouest, Saint-Herblain, France
- Institut Claudius Regaud, Toulouse, France
- Institut Gustave Roussy, Villejuif, France
Collaborators
Merck Sharp & Dohme LLC · Ministry of Health, France · Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02406781 on ClinicalTrials.govOther trials for Bone sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07479732Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaPeking University People's Hospital
- RECRUITINGPHASE1NCT07222735Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory SarcomasSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07359053MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced SarcomaShanghai 6th People's Hospital
- RECRUITINGPHASE2NCT06939855QL1706 in the Treatment of Advanced Bone and Soft Tissue SarcomaSun Yat-sen University
- RECRUITINGNCT07215611Financial Toxicity in Patients With Resected Soft Tissue and Bone SarcomasM.D. Anderson Cancer Center
- RECRUITINGNCT06958107LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma PatientsWake Forest University Health Sciences
- RECRUITINGPHASE1, PHASE2NCT07066982Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasEssen Biotech
- RECRUITINGNANCT06796543Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone SarcomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins